Agenda
Presentations
Meeting Summary
Recommendations
Recommendation 27
The ACBSCT recommends that the Secretary encourage the Centers for Medicare & Medicaid Services (CMS) to reimburse for the acquisition of blood stem cells, bone marrow, or umbilical cord blood products for hematopoietic stem cell transplant on a cost basis, consistent with CMS guidelines for solid organ transplants.
Accessibility Disclaimer
Persons using assistive technology may not be able to fully access information in these files. For assistance, contact comments@hrsa.gov or 888-275-4772 (TTY: 877-489-4772).